Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
Public ClinicalTrials.gov record NCT06161116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of MK-6194 in adult participants with systemic lupus erythematosus.
Study identification
- NCT ID
- NCT06161116
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2023
- Primary completion
- Jul 29, 2025
- Completion
- Jul 29, 2025
- Last update posted
- Aug 9, 2026
2023 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medvin Clinical Research - Metyas ( Site 0128) | Covina | California | 91722 | — |
| UCSD - Altman Clinical and Translational Research Institute (ACTRI)-Center for Innovative Therapy ( Site 0110) | La Jolla | California | 92037 | — |
| Arthritis & Osteoporosis Medical Center - La Palma ( Site 0108) | La Palma | California | 90623 | — |
| Medvin Clinical Research - Tujunga ( Site 0127) | Tujunga | California | 91042 | — |
| Denver Arthritis Clinic ( Site 0102) | Denver | Colorado | 80230 | — |
| Clinical Research of West Florida, Inc. (Clearwater) ( Site 0111) | Clearwater | Florida | 33765 | — |
| IRIS Research and Development, LLC-Research ( Site 0117) | Plantation | Florida | 33324 | — |
| Clinical Research of West Florida, Inc ( Site 0124) | Tampa | Florida | 33606 | — |
| Morehouse School of Medicine ( Site 0146) | Atlanta | Georgia | 30310 | — |
| Accurate Clinical Research, Inc ( Site 0135) | Lake Charles | Louisiana | 70605 | — |
| AA Medical Research Center ( Site 0136) | Grand Blanc | Michigan | 48439 | — |
| Javara - Tryon Medical Partners ( Site 0121) | Charlotte | North Carolina | 28210 | — |
| DJL Clinical Research, PLLC ( Site 0103) | Charlotte | North Carolina | 28211 | — |
| University of Oklahoma Health Science Center ( Site 0130) | Oklahoma City | Oklahoma | 73104 | — |
| Shelby Research, LLC ( Site 0142) | Memphis | Tennessee | 38119 | — |
| Accurate Clinical Management, LLC. ( Site 0134) | Baytown | Texas | 77521 | — |
| Epic Medical Research ( Site 0113) | DeSoto | Texas | 75115 | — |
| Accurate Clinical Research, Inc. ( Site 0133) | Houston | Texas | 77089 | — |
| SouthWest Rheumatology Research, LLC ( Site 0115) | Mesquite | Texas | 75150 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 108 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06161116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06161116 live on ClinicalTrials.gov.